Tenders/ADALIMUMAB INJ 40 MG
Open🇯🇴JordanSupplies

ADALIMUMAB INJ 40 MG

وزارة الصحة
Published: Nov 15, 2026
Updated: Nov 15, 2026
Source: JONEPS Jordan

About This Opportunity

This is a supplies contract in the general supplies and health and medical services sectors, with a focus on Pharmaceuticals. Located in Jordan, Middle East & North Africa, this opportunity is open to firms and consortiums.

Published through JONEPS Jordan, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the general supplies sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. Interested parties should review the full documentation on the original source before submitting their proposal.

Description

This tender from the Hashemite Kingdom of Jordan is for the procurement of Adalimumab injections, specifically at a dosage of 40 mg. Adalimumab is a biologic medication used to treat various autoimmune diseases, such as rheumatoid arthritis, Crohn's disease, and psoriasis. This procurement is for essential pharmaceutical supplies for patient treatment. The tender will require suppliers to provide Adalimumab injections that meet stringent pharmaceutical standards, including regulatory approval from relevant health authorities and adherence to Good Manufacturing Practices (GMP). Key requirements will include the specific formulation, concentration (40 mg per injection), presentation (e.g., pre-filled syringes), packaging, expiry dates, and storage conditions (typically requiring refrigeration). Bidders must demonstrate their ability to supply authentic, high-quality medication. Documentation such as product registration, batch certificates, and proof of cold chain management will be essential. The evaluation criteria will focus on the quality and authenticity of the drug, compliance with all regulatory and technical specifications, reliability of supply, and the financial offer. Ensuring the availability of this critical medication is paramount for patient health outcomes.

Data provenance

This notice is sourced from JONEPS Jordan and was originally published on November 15, 2026. Last refreshed today. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About وزارة الصحة

وزارة الصحة has issued 2,665 procurement notices on BidsFactory, including 86 currently open and 0 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Construction & Civil Works. All notices are published for Jordan. Notices are distributed via JONEPS Jordan. Most recent publication: November 15, 2026.

Frequently asked questions about this tender

How can I submit a bid?

Visit JONEPS Jordan to access the full notice, required documents, and submission instructions provided by the contracting authority.

Who is the contracting authority?

This notice was issued by وزارة الصحة in Jordan. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

What type of contract is this?

This is a Supplies contract in the General Supplies & Services sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

Where will the contract be performed?

The contract is for delivery in Jordan. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.

Find tenders like this automatically

Premium shows the full details of every tender like this one and alerts you instantly when a new one is published.

See plans

Key Details

Contract Type
Supplies
Eligibility
Firms / Consortiums
Language
English

Source

joneps_jo
JONEPS Jordan
Public Procurement

Contracting Authority

وزارة الصحة
🇯🇴Jordan